TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Singapore S.E.
Equities
T14
CNE100000924
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.43 USD | -2.02% |
|
+4.29% | +17.39% |
| May. 15 | Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Announces Directorate and Committee Changes | CI |
| Apr. 30 | Tianjin Pharmaceutical's Q1 Profit, Revenue Fall 3% | MT |
Evolution of the average Target Price on Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
Price target over the last 5 years
History of analyst recommendation changes
7757d765f7c3a9dd5.cL5VniNKVgydI-TJ_N4cqZl7huWavMUjpqIW6QXU3lk.FfFs0lc_Mn_CEda-iuhb-ulJ6ofDiadT9-svhDThq28G8DPsUSwzaNYQvQ~712ac65e92a925f069d7ba49928a58d2
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
33.17
CNY
Average target price
45.8
CNY
Spread / Average Target
+38.08%
High Price Target
45.8
CNY
Spread / Highest target
+38.08%
Low Price Target
45.8
CNY
Spread / Lowest Target
+38.08%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600329 Stock
- T14 Stock
- Consensus Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
